Form 10-Q
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 10-Q

 

 

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: November 30, 2018

Or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from:                      To:                     

Commission File Number: 000-23996

 

 

SCHMITT INDUSTRIES, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Oregon   93-1151989

(State or other jurisdiction of

incorporation or organization)

 

(IRS Employer

Identification Number)

2765 NW Nicolai Street, Portland, Oregon 97210-1818

(Address of principal executive offices) (Zip Code)

(503) 227-7908

 

 

Indicate by check mark whether the registrant has (1) filed all reports required to be filed by Section 13 of 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (check one):

 

Large accelerated filer      Accelerated filer  
Non-accelerated filer      Smaller reporting company  
     Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☒

The number of shares of each class of common stock outstanding as of December 31, 2018

 

Common stock, no par value

     3,994,545  

 

 

 


Table of Contents

SCHMITT INDUSTRIES, INC.

INDEX TO FORM 10-Q

 

         Page  

Part I - FINANCIAL INFORMATION

 

Item 1.

 

Financial Statements:

  
  Consolidated Balance Sheets:
November 30, 2018 and May 31, 2018 (unaudited)
     3  
  Consolidated Statements of Operations and Comprehensive Income (Loss):
For the Three and Six Months Ended November 30, 2018 and 2017 (unaudited)
     4  
  Consolidated Statements of Cash Flows:
For the Six Months Ended November 30, 2018 and 2017 (unaudited)
     5  
  Consolidated Statement of Changes in Stockholders’ Equity:
For the Six Months Ended November 30, 2018 (unaudited)
     6  
 

Notes to Consolidated Interim Financial Statements

     7  

Item 2.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

     14  

Item 3.

 

Quantitative and Qualitative Disclosures About Market Risk

     19  

Item 4.

 

Controls and Procedures

     19  

Part II - OTHER INFORMATION

  

Item 1.

 

Legal Proceedings

     20  

Item 6.

 

Exhibits

     20  

Signatures

       21  

Certifications

    

 

Page 2


Table of Contents

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

SCHMITT INDUSTRIES, INC.

CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

 

     November 30, 2018     May 31, 2018  
ASSETS

 

Current assets

    

Cash and cash equivalents

   $ 1,299,886     $ 2,053,181  

Restricted cash

     56,583       58,352  

Accounts receivable, net

     2,184,906       2,047,032  

Inventories

     6,077,054       5,710,888  

Prepaid expenses

     136,004       148,924  

Income taxes receivable

     4,435       0  
  

 

 

   

 

 

 

Total current assets

     9,758,868       10,018,377  
  

 

 

   

 

 

 

Property and equipment, net

     734,687       770,915  
  

 

 

   

 

 

 

Other assets

    

Intangible assets, net

     444,476       496,768  
  

 

 

   

 

 

 

TOTAL ASSETS

   $ 10,938,031     $ 11,286,060  
  

 

 

   

 

 

 
LIABILITIES & STOCKHOLDERS’ EQUITY

 

Current liabilities

    

Accounts payable

   $ 1,159,569     $ 1,024,256  

Accrued commissions

     191,281       194,797  

Accrued payroll liabilities

     186,488       188,568  

Other accrued liabilities

     269,402       358,790  

Income taxes payable

     0       3,993  
  

 

 

   

 

 

 

Total current liabilities

     1,806,740       1,770,404  
  

 

 

   

 

 

 

Stockholders’ equity

    

Common stock, no par value, 20,000,000 shares authorized, 3,994,545 shares issued and outstanding at November 30, 2018 and May 31, 2018

     13,094,639       13,085,652  

Accumulated other comprehensive loss

     (462,570     (536,307

Accumulated deficit

     (3,500,778     (3,033,689
  

 

 

   

 

 

 

Total stockholders’ equity

     9,131,291       9,515,656  
  

 

 

   

 

 

 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

   $ 10,938,031     $ 11,286,060  
  

 

 

   

 

 

 

The accompanying notes are an integral part of these financial statements.

 

Page 3


Table of Contents

SCHMITT INDUSTRIES, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

FOR THE THREE AND SIX MONTHS ENDED NOVEMBER 30, 2018 AND 2017

(UNAUDITED)

 

     Three Months Ended November 30,      Six Months Ended November 30,  
     2018     2017      2018     2017  

Net sales

   $ 3,503,478     $ 3,770,880      $ 6,943,931     $ 6,854,528  

Cost of sales

     2,140,371       2,044,898        4,241,026       3,729,027  
  

 

 

   

 

 

    

 

 

   

 

 

 

Gross profit

     1,363,107       1,725,982        2,702,905       3,125,501  
  

 

 

   

 

 

    

 

 

   

 

 

 

Operating expenses:

         

General, administration and sales

     1,539,495       1,524,443        2,944,858       2,992,787  

Research and development

     47,924       100,760        96,161       177,217  
  

 

 

   

 

 

    

 

 

   

 

 

 

Total operating expenses

     1,587,419       1,625,203        3,041,019       3,170,004  
  

 

 

   

 

 

    

 

 

   

 

 

 

Operating income (loss)

     (224,312     100,779        (338,114     (44,503

Other income (expense), net

     (24,596     9,078        (116,247     26,621  
  

 

 

   

 

 

    

 

 

   

 

 

 

Income (loss) before income taxes

     (248,908     109,857        (454,361     (17,882

Provision for income taxes

     6,362       6,609        12,728       12,968  
  

 

 

   

 

 

    

 

 

   

 

 

 

Net income (loss)

   $ (255,270   $ 103,248      $ (467,089   $ (30,850
  

 

 

   

 

 

    

 

 

   

 

 

 

Net income (loss) per common share:

         

Basic

   $ (0.06   $ 0.03      $ (0.12   $ (0.01
  

 

 

   

 

 

    

 

 

   

 

 

 

Weighted average number of common shares, basic

     3,994,545       2,995,910        3,994,545       2,995,910  
  

 

 

   

 

 

    

 

 

   

 

 

 

Diluted

   $ (0.06   $ 0.03      $ (0.12   $ (0.01
  

 

 

   

 

 

    

 

 

   

 

 

 

Weighted average number of common shares, diluted

     3,994,545       3,024,099        3,994,545       2,995,910  
  

 

 

   

 

 

    

 

 

   

 

 

 

Comprehensive income (loss)

         

Net income (loss)

   $ (255,270   $ 103,248      $ (467,089   $ (30,850

Foreign currency translation adjustment

     (5,907     15,164        73,737       440  
  

 

 

   

 

 

    

 

 

   

 

 

 

Total comprehensive income (loss)

   $ (261,177   $ 118,412      $ (393,352   $ (30,410
  

 

 

   

 

 

    

 

 

   

 

 

 

The accompanying notes are an integral part of these financial statements.

 

Page 4


Table of Contents

SCHMITT INDUSTRIES, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS ENDED NOVEMBER 30, 2018 AND 2017

(UNAUDITED)

 

     Six Months Ended November 30,  
     2018     2017  

Cash flows relating to operating activities

    

Net loss

   $ (467,089   $ (30,850

Adjustments to reconcile net loss to net cash used in operating activities:

    

Depreciation and amortization

     93,933       104,645  

(Gain) loss on disposal of property and equipment

     0       619  

Stock based compensation

     8,987       40,839  

(Increase) decrease in:

    

Accounts receivable

     (156,969     218,163  

Inventories

     (384,280     (569,393

Prepaid expenses

     12,081       11,286  

Income taxes receivable

     (4,435     6,596  

Increase (decrease) in:

    

Accounts payable

     138,428       97,824  

Accrued liabilities and customer deposits

     (89,889     (114,766

Income taxes payable

     (3,993     0  
  

 

 

   

 

 

 

Net cash used in operating activities

     (853,226     (235,037
  

 

 

   

 

 

 

Cash flows relating to investing activities

    

Purchases of property and equipment

     (5,517     (8,467

Proceeds from the sale of property and equipment

     0       1,500  
  

 

 

   

 

 

 

Net cash used in investing activities

     (5,517     (6,967
  

 

 

   

 

 

 

Effect of foreign exchange translation on cash

     103,679       (38,617
  

 

 

   

 

 

 

Decrease in cash, cash equivalents and restricted cash

     (755,064     (280,621

Cash, cash equivalents and restricted cash, beginning of period

     2,111,533       867,607  
  

 

 

   

 

 

 

Cash, cash equivalents and restricted cash, end of period

   $ 1,356,469     $ 586,986  
  

 

 

   

 

 

 

Supplemental disclosure of cash flow information

    

Cash paid during the period for income taxes

   $ 21,155     $ 6,322  
  

 

 

   

 

 

 

Cash paid during the period for interest

   $ 462     $ 785  
  

 

 

   

 

 

 

The accompanying notes are an integral part of these financial statements.

 

Page 5


Table of Contents

SCHMITT INDUSTRIES, INC.

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE SIX MONTHS ENDED NOVEMBER 30, 2018

(UNAUDITED)

 

     Shares      Amount      Accumulated
other
comprehensive
loss
    Accumulated
deficit
    Total  

Balance, May 31, 2018

     3,994,545      $ 13,085,652      $ (536,307   $ (3,033,689   $ 9,515,656  

Stock-based compensation

     0        8,987        0       0       8,987  

Net loss

     0        0        0       (467,089     (467,089

Other comprehensive loss

     0        0        73,737       0       73,737  
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

 

Balance, November 30, 2018

     3,994,545      $ 13,094,639      $ (462,570   $ (3,500,778   $ 9,131,291  
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

 

The accompanying notes are an integral part of these financial statements.

 

Page 6


Table of Contents

SCHMITT INDUSTRIES, INC.

NOTES TO CONSOLIDATED INTERIM FINANCIAL STATEMENTS

NOTE 1:

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The consolidated financial information included herein has been prepared by Schmitt Industries, Inc. (the Company or Schmitt) and its wholly owned subsidiaries. In the opinion of management, the accompanying unaudited Consolidated Financial Statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission and contain all adjustments, consisting only of normal recurring adjustments, necessary to present fairly its financial position as of November 30, 2018 and its results of operations and its cash flows for the periods presented. The consolidated balance sheet at May 31, 2018 has been derived from the Annual Report on Form 10-K for the fiscal year ended May 31, 2018. The accompanying unaudited financial statements and related notes should be read in conjunction with the audited financial statements included in our Annual Report on Form 10-K for the fiscal year ended May 31, 2018. Operating results for the interim periods presented are not necessarily indicative of the results that may be experienced for the fiscal year ending May 31, 2019.

Revenue Recognition

On June 1, 2018, the Company adopted Accounting Standards Update (ASU) No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” using the modified retrospective approach. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements or related disclosures.

The Company determines the amount of revenue it recognizes associated with the transfer of each product or service using the five-step model provided by Topic 606. For sales of products or delivery of monitoring services to all customers, including manufacturing representatives, distributors or their third-party customers, each transaction is evaluated to determine whether there is approval and commitment from both the Company and the customer for the transaction; whether the rights of each party are specifically identified; whether the transaction has commercial substance; whether collectability from the customer is probable at the inception of the contract and whether the transaction amount is defined. If a transaction to sell products or provide monitoring services meets all of the above criteria, revenue is recognized for the sales of product at the time of shipment or for monitoring services at the completion of the month in which monitoring services are provided.

The Company incurs commissions associated with the sales of products, which are accrued and expensed at the time the product is shipped. These amounts are recorded within general, administration and sales expense.

The Company also incurs costs related to shipping and handling of its products, the costs of which are expensed as incurred as a component of cost of sales. Shipping and handling fees billed to customers are recognized at the time of shipment as a component of net sales.

Financial Instruments

The carrying value of all other financial instruments potentially subject to valuation risk (principally consisting of cash and cash equivalents, accounts receivable and accounts payable) also approximates fair value because of their short-term maturities.

Restricted Cash

Restricted cash consists of an amount received from a customer in December 2017 as part of an on-going contract. The timeline for services being provided under this contract has been extended and is expected to be completed during the second half of Fiscal 2019, at which time the restrictions on this payment will lapse.

 

Page 7


Table of Contents

The following table provides a reconciliation of cash and cash equivalents and restricted cash as reported within the Consolidated Balance Sheets as of November 30, 2018 and May 31, 2018 to the sum of the same such amounts as shown in the Consolidated Statement of Cash Flows for the six months ended November 30, 2018:

 

     November 30, 2018      May 31, 2018  

Cash and cash equivalents

   $ 1,299,886      $ 2,053,181  

Restricted cash

     56,583        58,352  
  

 

 

    

 

 

 

Total cash, cash equivalents, and restricted cash shown in the Consolidated Statement of Cash Flows

   $ 1,356,469      $ 2,111,533  
  

 

 

    

 

 

 

Accounts Receivable

The Company maintains credit limits for all customers based upon several factors, including but not limited to financial condition and stability, payment history, published credit reports and use of credit references. Management performs various analyses to evaluate accounts receivable balances to ensure recorded amounts reflect estimated net realizable value. This review includes using accounts receivable agings, other operating trends and relevant business conditions, including general economic factors, as they relate to each of the Company’s domestic and international customers. If these analyses lead management to the conclusion that potential significant accounts are uncollectible, a reserve is provided. The allowance for doubtful accounts was $101,304 and $95,207 as of November 30, 2018 and May 31, 2018, respectively.

Inventories

Inventories are valued at the lower of cost or net realizable value with cost determined on the average cost basis. Costs included in inventories consist of materials, labor and manufacturing overhead, which are related to the purchase or production of inventories. Write-downs, when required, are made to reduce excess inventories to their net realizable values. Such estimates are based on assumptions regarding future demand and market conditions. If actual conditions become less favorable than the assumptions used, an additional inventory write-down may be required. As of November 30, 2018 and May 31, 2018, inventories consisted of:

 

     November 30, 2018      May 31, 2018  

Raw materials

   $ 2,822,375      $ 2,796,691  

Work-in-process

     1,045,126        1,009,424  

Finished goods

     2,209,553        1,904,773  
  

 

 

    

 

 

 
   $ 6,077,054      $ 5,710,888  
  

 

 

    

 

 

 

Property and Equipment

Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over estimated useful lives of three to seven years for furniture, fixtures and equipment; three years for vehicles; and twenty-five years for buildings and improvements. As of November 30, 2018 and May 31, 2018, property and equipment consisted of:

 

     November 30, 2018      May 31, 2018  

Land

   $ 299,000      $ 299,000  

Buildings and improvements

     1,814,524        1,814,524  

Furniture, fixtures and equipment

     1,257,784        1,252,598  

Vehicles

     44,704        44,704  
  

 

 

    

 

 

 
     3,416,012        3,410,826  

Less accumulated depreciation

     (2,681,325      (2,639,911
  

 

 

    

 

 

 
   $ 734,687      $ 770,915  
  

 

 

    

 

 

 

Recent Accounting Pronouncements

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), in order to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet for most leases previously classified as operating leases. The ASU is required to be applied using a modified retrospective approach at the beginning of the earliest period presented, with optional practical expedients. The FASB recently proposed an optional transition alternative, which would allow for application of the guidance at the beginning of the period in which it is adopted, rather than at the beginning of the earliest comparative period presented. The Company will adopt the new standard on June 1, 2019.

 

 

Page 8


Table of Contents

The Company is currently evaluating the impact of this guidance, including reviewing the standard’s provisions and gathering and analyzing data to support further evaluation of all real estate and non-real estate leases. The Company is also evaluating the impact of the accounting standard on the Company’s financial statement disclosures, systems, processes and controls.

NOTE 2:

STOCK OPTIONS AND STOCK-BASED COMPENSATION

Stock-based compensation includes expense charges for all stock-based awards to employees and directors granted under the Company’s stock option plan. Stock-based compensation recognized during the period is based on the portion of the grant date fair value of the stock-based award that will vest during the period, adjusted for expected forfeitures. Compensation cost for all stock-based awards is recognized using the straight-line method. The Company uses the Black-Scholes option pricing model as its method of valuation for stock-based awards. The Black-Scholes option pricing model requires the input of highly subjective assumptions, and other reasonable assumptions could provide differing results. These variables include, but are not limited to:

 

   

Risk-Free Interest Rate. The Company bases the risk-free interest rate on the implied yield currently available on U.S. Treasury issues with an equivalent remaining term approximately equal to the expected life of the award.

 

   

Expected Life. The expected life of awards granted represents the period of time that they are expected to be outstanding. The Company determines the expected life based on historical experience with similar awards, giving consideration to the contractual terms, vesting schedules and pre-vesting and post-vesting forfeitures.

 

   

Expected Volatility. The Company estimates the volatility of its common stock at the date of grant based on the historical volatility of its common stock. The volatility factor the Company uses is based on its historical stock prices over the most recent period commensurate with the estimated expected life of the award. These historical periods may exclude portions of time when unusual transactions occurred.

 

   

Expected Dividend Yield. The Company does not anticipate paying any cash dividends in the foreseeable future. Consequently, the Company uses an expected dividend yield of 0.

 

   

Expected Forfeitures. The Company uses relevant historical data to estimate pre-vesting option forfeitures. The Company records stock-based compensation only for those awards that are expected to vest.

To determine stock-based compensation expense recognized for those options granted during the six months ended November 30, 2018, the Company has computed the value of all stock options granted using the Black-Scholes option pricing model as prescribed by ASC Topic 718 using the following assumptions:

 

     Six Months Ended  
     November 30, 2018  

Risk-free interest rate

     3.1

Expected life

     6.0 years  

Expected volatility

     46.3

At November 30, 2018, the Company had a total of 334,999 outstanding stock options (289,164 vested and exercisable and 45,835 non-vested) with a weighted average exercise price of $2.38. The Company estimates that $17,386 will be recorded as additional stock-based compensation expense over a weighted-average period of 1.4 years for all options that were outstanding as of November 30, 2018, but which were not yet vested.

 

Page 9


Table of Contents
Outstanding Options     Exercisable Options  

Number of
Shares

    Weighted
Average
Exercise Price
    Weighted
Average
Remaining
Contractual
Life (yrs)
    Number of
Shares
    Weighted
Average
Exercise Price
 
  162,499     $ 1.70       7.7       131,664     $ 1.70  
  30,000       2.49       7.2       15,000       2.53  
  87,500       2.82       5.4       87,500       2.82  
  55,000       3.65       2.1       55,000       3.65  

 

 

       

 

 

   
  334,999       2.38       6.1       289,164       2.45  

 

 

       

 

 

   

Options granted, exercised, and forfeited or canceled under the Company’s stock option plan during the six months ended November 30, 2018 are summarized as follows:

 

     Six Months Ended
November 30, 2018
 
     Number of
Shares
     Weighted
Average
Exercise Price
 

Options outstanding - beginning of period

     318,332      $ 2.36  

Options granted

     25,000        2.53  

Options exercised

     0        0  

Options forfeited/canceled

     (8,333      1.70  
  

 

 

    

Options outstanding - end of period

     334,999        2.38  
  

 

 

    

NOTE 3:

EPS RECONCILIATION

 

     Three Months Ended
November 30,
     Six Months Ended
November 30,
 
     2018      2017      2018      2017  

Weighted average shares (basic)

     3,994,545        2,995,910        3,994,545        2,995,910  

Effect of dilutive stock options

     0        28,189        0        0  
  

 

 

    

 

 

    

 

 

    

 

 

 

Weighted average shares (diluted)

     3,994,545        3,024,099        3,994,545        2,995,910  
  

 

 

    

 

 

    

 

 

    

 

 

 

Basic earnings (loss) per share is computed using the weighted average number of common shares outstanding. Diluted earnings (loss) per share is computed using the weighted average number of common shares outstanding, adjusted for dilutive incremental shares attributed to outstanding options to purchase common stock.    Common stock equivalents for stock options are computed using the treasury stock method. In periods in which a net loss is incurred, no common stock equivalents are included since they are antidilutive and as such all stock options outstanding are excluded from the computation of diluted net loss in those periods.

 

Page 10


Table of Contents

NOTE 4:

INCOME TAXES

The Company accounts for income taxes using the asset and liability method. This approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of assets and liabilities. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Management continues to review the level of the valuation allowance on a quarterly basis. There can be no assurance that the Company’s future operations will produce sufficient earnings to allow for the deferred tax asset to be fully utilized. The Company currently maintains a full valuation allowance against net deferred tax assets.

Each year the Company files income tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the taxing authorities. Positions challenged by the taxing authorities may be settled or appealed by the Company. As a result, there is an uncertainty in income taxes recognized in the Company’s financial statements in accordance with ASC Topic 740. The Company applies this guidance by defining criteria that an individual income tax position must meet for any part of the benefit of that position to be recognized in an enterprise’s financial statements and provides guidance on measurement, de-recognition, classification, accounting for interest and penalties, accounting in interim periods, disclosure, and transition.

Other long-term liabilities related to tax contingencies were $0 as of both November 30, 2018 and May 31, 2018. Interest and penalties associated with uncertain tax positions are recognized as components of the “Provision for income taxes.” The liability for payment of interest and penalties was $0 as of November 30, 2018 and May 31, 2018.

Several tax years are subject to examination by major tax jurisdictions. In the United States, federal tax years ended May 31, 2015 and after are subject to examination. In the United Kingdom, tax years ended May 31, 2013 and after are subject to examination.

Effective Tax Rate

The effective tax rate on consolidated net loss was 2.8% for the six months ended November 30, 2018. The effective tax rate on consolidated net loss differs from the federal statutory tax rate primarily due to changes in the deferred tax valuation allowance and certain expenses not being deductible for income tax reporting purposes. Management believes the effective tax rate for Fiscal 2019 will be approximately 9.8% due to the items noted above.

NOTE 5:

SEGMENTS OF BUSINESS

The Company has two reportable business segments: dynamic balancing and process control systems for the machine tool industry (Balancer) and laser-based test and measurement systems and ultrasonic measurement products (Measurement). The Company operates in three principal geographic markets: North America, Europe and Asia.

 

Page 11


Table of Contents

Segment Information

 

     Three Months Ended November 30,  
     2018      2017  
     Balancer      Measurement      Balancer      Measurement  

Net sales

   $ 2,345,480      $ 1,157,998      $ 2,230,846      $ 1,540,034  
  

 

 

    

 

 

    

 

 

    

 

 

 

Operating income (loss)

   $ (343,717    $ 119,405      $ (88,986    $ 189,765  
  

 

 

    

 

 

    

 

 

    

 

 

 

Depreciation expense

   $ 11,571      $ 8,999      $ 16,388      $ 9,361  
  

 

 

    

 

 

    

 

 

    

 

 

 

Amortization expense

   $ 0      $ 26,146      $ 0      $ 26,146  
  

 

 

    

 

 

    

 

 

    

 

 

 

Capital expenditures

   $ 267      $ 0      $ 889      $ 0  
  

 

 

    

 

 

    

 

 

    

 

 

 
     Six Months Ended November 30,  
     2018      2017  
     Balancer      Measurement      Balancer      Measurement  

Net sales

   $ 4,539,812      $ 2,404,119      $ 4,301,243      $ 2,553,285  
  

 

 

    

 

 

    

 

 

    

 

 

 

Operating income (loss)

   $ (606,218    $ 268,104      $ (300,766    $ 256,263  
  

 

 

    

 

 

    

 

 

    

 

 

 

Depreciation expense

   $ 23,643      $ 17,998      $ 33,370      $ 18,983  
  

 

 

    

 

 

    

 

 

    

 

 

 

Amortization expense

   $ 0      $ 52,292      $ 0      $ 52,292  
  

 

 

    

 

 

    

 

 

    

 

 

 

Capital expenditures

   $ 5,517      $ 0      $ 8,467      $ 0  
  

 

 

    

 

 

    

 

 

    

 

 

 

Geographic Information – Net Sales by Geographic Area

 

     Three Months Ended November 30,      Six Months Ended November 30,  
     2018      2017      2018      2017  

North America

   $ 1,965,706      $ 2,484,977      $ 4,165,907      $ 4,276,078  

Europe

     505,788        457,036        879,251        974,899  

Asia

     977,175        795,483        1,801,951        1,544,905  

Other markets

     54,809        33,384        96,822        58,646  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total net sales

   $ 3,503,478      $ 3,770,880      $ 6,943,931      $ 6,854,528  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

Page 12


Table of Contents
     Three Months Ended November 30,  
     2018      2017  
     United States (2)      Europe (1)      United States (2)      Europe (1)  

Operating income (loss)

   $ (262,909    $ 38,597      $ 31,655      $ 69,124  
  

 

 

    

 

 

    

 

 

    

 

 

 

Depreciation expense

   $ 20,570      $ 0      $ 25,749      $ 0  
  

 

 

    

 

 

    

 

 

    

 

 

 

Amortization expense

   $ 26,146      $ 0      $ 26,146      $ 0  
  

 

 

    

 

 

    

 

 

    

 

 

 

Capital expenditures

   $ 267      $ 0      $ 889      $ 0  
  

 

 

    

 

 

    

 

 

    

 

 

 
     Six Months Ended November 30,  
     2018      2017  
     United States (2)      Europe (1)      United States (2)      Europe (1)  

Operating income (loss)

   $ (394,099      55,985      $ (183,810      139,307  
  

 

 

    

 

 

    

 

 

    

 

 

 

Depreciation expense

   $ 41,641      $ 0      $ 52,353      $ 0  
  

 

 

    

 

 

    

 

 

    

 

 

 

Amortization expense

   $ 52,292      $ 0      $ 52,292      $ 0  
  

 

 

    

 

 

    

 

 

    

 

 

 

Capital expenditures

   $ 5,517      $ 0      $ 8,467      $ 0  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(1)

“Europe” is defined in the above chart to include results from the European subsidiary, Schmitt Europe Ltd.

(2)

“United States” is defined to include remainder of the results not included in the European subsidiary.

Segment and Geographic Assets

 

     November 30, 2018      May 31, 2018  

Segment assets to total assets

     

Balancer

   $ 6,505,775      $ 6,461,974  

Measurement

     3,071,352        2,712,553  

Corporate assets

     1,360,904        2,111,533  
  

 

 

    

 

 

 

Total assets

   $ 10,938,031      $ 11,286,060  
  

 

 

    

 

 

 

Geographic assets to long-lived assets

     

United States (2)

   $ 734,687      $ 770,915  

Europe (1)

     0        0  
  

 

 

    

 

 

 

Total long-lived assets

   $ 734,687      $ 770,915  
  

 

 

    

 

 

 

Geographic assets to total assets

     

United States (2)

   $ 9,748,277      $ 10,110,683  

Europe (1)

     1,189,754        1,175,377  
  

 

 

    

 

 

 

Total assets

   $ 10,938,031      $ 11,286,060  
  

 

 

    

 

 

 

 

(1)

“Europe” includes assets held by the European subsidiary, Schmitt Europe Ltd.

(2)

“United States” includes remainder of the assets not held by the European subsidiary.

 

Page 13


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This Quarterly Report filed with the SEC on Form 10-Q (the “Report”), including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this Item 2, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding future events and the future results of Schmitt Industries, Inc. and its consolidated subsidiaries (the “Company”) that are based on management’s current expectations, estimates, projections and assumptions about the Company’s business. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “sees,” “estimates” and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including, but not limited to, those discussed in the “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this Report as well as those discussed from time to time in the Company’s other Securities and Exchange Commission filings and reports. In addition, such statements could be affected by general industry and market conditions. Such forward-looking statements speak only as of the date of this Report or, in the case of any document incorporated by reference, the date of that document, and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this Report. If we update or correct one or more forward-looking statements, investors and others should not conclude that we will make additional updates or corrections with respect to other forward-looking statements.

RESULTS OF OPERATIONS

Overview

Schmitt Industries, Inc. (the Company), an Oregon corporation, designs, manufactures and sells high precision test and measurement products for two main business segments: the Balancer segment and the Measurement segment. For the Balancer segment, the Company designs, manufactures and sells computer-controlled vibration detection, balancing and process control systems for the worldwide machine tool industry, particularly for grinding machines. The Company also provides sales and service for Europe and Asia through its wholly owned subsidiary, Schmitt Europe Limited (SEL), located in Coventry, England and through its sales representative office located in Shanghai, China. For the Measurement segment, the Company designs, manufacturers and sells products in two core product lines: the Acuity® product line, which includes laser and white light sensor distance, measurement and dimensional sizing products; and the Xact® product line, which includes remote tank monitoring products that measure the fill levels of tanks holding propane, diesel and other tank-based liquids and the related monitoring services, which includes transmission of fill data from the tanks via satellite to a secure web site for display. The accompanying unaudited financial information should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended May 31, 2018.

“SBS,” “SMS,” “Acuity,” “Xact”, “Lasercheck” and “AccuProfile” are registered trademarks owned by the Company.

Highlights of the Three and Six Months Ended November 30, 2018

 

   

Balancer segment sales increased $114,634, or 5.1%, to $2,345,480 for the three months ended November 30, 2018 as compared to $2,230,846 for the three months ended November 30, 2017. Balancer segment sales increased $238,569, or 5.5%, to $4,539,812 for the six months ended November 30, 2018 as compared to $4,301,243 for the six months ended November 30, 2017.

 

   

Measurement segment sales decreased $382,036, or 24.8%, to $1,157,998 for the three months ended November 30, 2018 as compared to $1,540,034 for the three months ended November 30, 2017. Measurement segment sales decreased $149,166, or 5.8%, to $2,404,119 for the six months ended November 30, 2018 from $2,553,285 for the six months ended November 30, 2017.

 

   

Within the Measurement segment, Xact monitoring revenues continued to grow, increasing 19.0% for the three months ended November 30, 2018 compared to the three months ended November 30, 2017. Xact monitoring revenues increased 17.0% for the six months ended November 30, 2018 as compared to the same period in the prior year.

 

Page 14


Table of Contents
   

Operating expenses decreased $37,784, or 2.3%, to $1,587,419 for the three months November 30, 2018 from $1,625,203 for the three months ended November 30, 2017, and decreased $128,985, or 4.1%, to $3,041,019 for the six months ended November 30, 2018 compared to $3,170,004 for the six months ended November 30, 2017. These results include non-recurring 2018 proxy and reorganization expenses of $125,280 and $257,330 incurred during the three-month and six-month periods ended November 30, 2018, respectively, that were not incurred during the same periods in the prior year.

Critical Accounting Policies

There were no material changes in our critical accounting policies as disclosed in our Annual Report on Form 10-K for the year ended May 31, 2018, other than the adoption of Accounting Standards Update (ASU) No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” which the Company adopted on June 1, 2018. See Note 1 “Revenue Recognition” for further discussion and disclosures related to the adoption of ASU No. 2014-09.

Discussion of Operating Results

 

     Three Months Ended  
     November 30, 2018     November 30, 2017  

Balancer sales

   $ 2,345,480        66.9   $ 2,230,846        59.2

Measurement sales

     1,157,998        33.1     1,540,034        40.8
  

 

 

      

 

 

    

Total net sales

     3,503,478        100.0     3,770,880        100.0

Cost of sales

     2,140,371        61.1     2,044,898        54.2
  

 

 

      

 

 

    

Gross profit

     1,363,107        38.9     1,725,982        45.8
  

 

 

      

 

 

    

Operating expenses:

          

General, administration and sales

     1,539,495        43.9     1,524,443        40.4

Research and development

     47,924        1.4     100,760        2.7
  

 

 

      

 

 

    

Total operating expenses

     1,587,419        45.3     1,625,203        43.1
  

 

 

      

 

 

    

Operating income (loss)

     (224,312      (6.4 %)      100,779        2.7

Other income (expense), net

     (24,596      (0.7 %)      9,078        0.2
  

 

 

      

 

 

    

Income (loss) before income taxes

     (248,908      (7.1 %)      109,857        2.9

Provision for income taxes

     6,362        0.2     6,609        0.2
  

 

 

      

 

 

    

Net income (loss)

   $ (255,270      (7.3 %)    $ 103,248        2.7
  

 

 

      

 

 

    
     Six Months Ended  
     November 30, 2018     November 30, 2017  

Balancer sales

   $ 4,539,812        65.4   $ 4,301,243        62.8

Measurement sales

     2,404,119        34.6     2,553,285        37.2
  

 

 

      

 

 

    

Total net sales

     6,943,931        100.0     6,854,528        100.0

Cost of sales

     4,241,026        61.1     3,729,027        54.4
  

 

 

      

 

 

    

Gross profit

     2,702,905        38.9     3,125,501        45.6
  

 

 

      

 

 

    

Operating expenses:

          

General, administration and sales

     2,944,858        42.4     2,992,787        43.7

Research and development

     96,161        1.4     177,217        2.6
  

 

 

      

 

 

    

Total operating expenses

     3,041,019        43.8     3,170,004        46.2
  

 

 

      

 

 

    

Operating loss

     (338,114      (4.9 %)      (44,503      (0.6 %) 

Other income (expense), net

     (116,247      (1.7 %)      26,621        0.4
  

 

 

      

 

 

    

Loss before income taxes

     (454,361      (6.5 %)      (17,882      (0.3 %) 

Provision for income taxes

     12,728        0.2     12,968        0.2
  

 

 

      

 

 

    

Net loss

   $ (467,089      (6.7 %)    $ (30,850      (0.5 %) 
  

 

 

      

 

 

    

 

Page 15


Table of Contents

Net Sales – Total net sales for the Company decreased $267,402, or 7.1%, to $3,503,478 for the three months ended November 30, 2018 from $3,770,880 for the three months ended November 30, 2017. Total net sales for the Company increased $89,403, or 1.3%, to $6,943,931 for the six months ended November 30, 2018 from $6,854,528 for the six months ended November 30, 2017.

Balancer Segment – The Balancer segment focuses its sales efforts on end-users, rebuilders and original equipment manufacturers of grinding machines within the worldwide machine tool industry, with our primary target geographic markets being North America, Asia, and Europe. Balancer segment sales increased $114,634, or 5.1%, to $2,345,480 for the three months ended November 30, 2018 as compared to $2,230,846 for the three months ended November 30, 2017. Balancer segment sales increased $238,569, or 5.5%, to $4,539,812 for the six months ended November 30, 2018 as compared to $4,301,243 for the six months ended November 30, 2017. The increase in the three-month results was primarily attributed to stronger sales in Asia, offset by decreased sales in North America. The increase in the six-month results was primarily driven by stronger sales in Asia, offset by decreased sales in both the North American and European markets.

Sales by geographic markets for the Balancer segment for the three and six months ended November 30, 2018 and 2017 were as follows:

 

     Three Months Ended November 30,                
     2018      2017      Variance  

North America

   $ 881,715      $ 1,062,738      $ (181,023      (17.0 %) 

Asia

     929,507        630,672        298,835        47.4

Europe

     498,700        520,162        (21,462      (4.1 %) 

Other

     35,558        17,274        18,284        105.8
  

 

 

    

 

 

    

 

 

    

Total Balancer segment sales

   $ 2,345,480      $ 2,230,846      $ 114,634        5.1
  

 

 

    

 

 

    

 

 

    
     Six Months Ended November 30,                
     2018      2017      Variance  

North America

   $ 1,872,596      $ 1,912,880      $ (40,284      (2.1 %) 

Asia

     1,719,093        1,377,469        341,624        24.8

Europe

     870,552        968,358        (97,806      (10.1 %) 

Other

     77,571        42,536        35,035        82.4
  

 

 

    

 

 

    

 

 

    

Total Balancer segment sales

   $ 4,539,812      $ 4,301,243      $ 238,569        5.5
  

 

 

    

 

 

    

 

 

    

The levels of demand for our Balancer products in any of these geographic markets cannot be forecasted with any certainty given current economic trends and the historical volatility experienced in this market.

Measurement Segment – The Measurement segment includes two main product lines: the Acuity® product line, which includes laser-based distance measurement and dimensional sizing laser sensors; and the Xact® product line, which includes ultrasonic-based remote tank monitoring products and related monitoring revenues. Measurement segment sales decreased $382,036, or 24.8%, to $1,157,998 for the three months ended November 30, 2018 as compared to $1,540,034 for the three months ended November 30, 2017. This decrease is primarily driven by a one-time significant contract in Acuity that was realized in the second quarter of Fiscal 2018. In addition, Xact product sales decreased in the second quarter of Fiscal 2019 as compared to the same period in the prior year as a result of the shift in timing of deliveries associated with one of Xact’s major customer’s planned deployment schedule. These decreases were offset by the increase in Xact monitoring revenues, which increased 19.0% as product previously sold was deployed and measurements began.

Measurement segment sales decreased $149,166, or 5.8%, to $2,404,119 for the six months ended November 30, 2018 from $2,553,285 for the six months ended November 30, 2017. This decrease is primarily driven by a one-time large contract in Acuity that was realized in the second quarter of Fiscal 2018 and softer sales that occurred for Acuity during the first quarter of Fiscal 2019 as compared to the same period in the prior year. This decrease was offset by the increases in Xact product sales and monitoring revenues. The increase in Xact product sales was driven by very strong results experienced in the first quarter of Fiscal 2019. Xact monitoring revenues increased 17.0% in the six months ended November 30, 2018 as compared to the same period in the prior year as product previously sold was deployed and measurements began.

 

Page 16


Table of Contents

Sales by product line for the Measurement segment for the three and six months ended November 30, 2018 and 2017 were as follows:

 

     Three Months Ended November 30,                
     2018      2017      Variance  

Acuity

   $ 541,978      $ 837,575      $ (295,597      (35.3 %) 

Xact - product sales

     267,698        351,666        (83,968      (23.9 %) 

Xact - monitoring revenues

     337,125        283,226        53,899        19.0

Lasercheck

     0        46,950        (46,950      (100.0 %) 

SMS

     11,197        20,617        (9,420   
  

 

 

    

 

 

    

 

 

    

Total Measurement segment sales

   $ 1,157,998      $ 1,540,034      $ (382,036      (24.8 %) 
  

 

 

    

 

 

    

 

 

    
     Six Months Ended November 30,                
     2018      2017      Variance  

Acuity

   $ 962,350      $ 1,420,210      $ (457,860      (32.2 %) 

Xact - product sales

     776,524        499,686        276,838        55.4

Xact - monitoring revenues

     653,298        558,182        95,116        17.0

Lasercheck

     0        54,590        (54,590      (100.0 %) 

SMS

     11,947        20,617        (8,670   
  

 

 

    

 

 

    

 

 

    

Total Measurement segment sales

   $ 2,404,119      $ 2,553,285      $ (149,166      (5.8 %) 
  

 

 

    

 

 

    

 

 

    

Gross Margin – Gross margin for the three months ended November 30, 2018 decreased to 38.9% as compared to 45.8% for the three months ended November 30, 2017. Gross margin for the six months ended November 30, 2018 decreased to 38.9% as compared to 45.6% for the six months ended November 30, 2017. The variances in gross margin between the periods presented were influenced by sales mix across the Company’s three product lines, increases in overall product costs incurred due to prior purchasing practices, and the shift in SBS product sales from the European and North American markets into the Asian markets which we expect to moderate in the second half of Fiscal 2019.

Operating Expenses – Operating expenses decreased $37,784, or 2.3%, to $1,587,419 for the three months November 30, 2018 from $1,625,203 for the three months ended November 30, 2017. The decrease in operating expenses was driven, in part, by the following:

 

   

Decrease in administrative wages and related payroll expenses in the amount of $77,479, or 20.4%, related to the realigning of the management team which occurred in the second half of Fiscal 2018. The results include $42,500 in non-recurring 2018 proxy and reorganization expenses that were incurred during the three months ended November 30, 2018 that were not incurred during the same period in the prior year;

 

   

Decrease in research and development expense in the amount of $52,836, or 52.4%, as a result of the shift of engineering resources towards support of existing product initiatives rather than research and development; and

 

   

Decrease in commission expense in the amount of $109,227, or 38.9%, as a result of the restructuring of the Company’s sales commissions programs that occurred during Fiscal 2018.

These decreases were offset by:

 

   

Increase in legal and other professional expenses in the amount of $133,545, or 41.3%, which includes $82,780 in non-recurring 2018 proxy and reorganization expenses that were incurred during the three months ended November 30, 2018 that were not incurred during the same period in the prior year; and

 

   

Increase in trade show expenses in the amount of $45,425, or 70.2%, related to the 2018 IMTS trade show, which only occurs every other year.

Operating expenses decreased $128,985, or 4.1%, to $3,041,019 for the six months November 30, 2018 from $3,170,004 for the six months ended November 30, 2017. The decrease in operating expenses was driven, in part, by the following:

 

   

Decrease in administrative wages and related payroll expenses in the amount of $189,910, or 24.5%, related to the realigning of the management team which occurred in the second half of Fiscal 2018. The results include $42,500 in non-recurring 2018 proxy and reorganization expenses that were incurred during the six months ended November 30, 2018 that were not incurred during the same period in the prior year;

 

   

Decrease in research and development expense in the amount of $81,056, or 45.7%, as a result of the shift of engineering resources towards support of existing product initiatives rather than research and development; and

 

Page 17


Table of Contents
   

Decrease in commission expense in the amount of $141,317, or 26.7%, as a result of the restructuring of the Company’s sales commissions programs that occurred during Fiscal 2018.

These decreases were offset by:

 

   

Increase in legal and other professional expenses in the amount of $295,700, or 52.9%, which includes $214,830 in non-recurring 2018 proxy and reorganization expenses that were incurred during the six months ended November 30, 2018 that were not incurred during the same period in the prior year; and

 

   

Increase in trade show expenses in the amount of $39,970, or 37.4%, related to the 2018 IMTS trade show, which only occurs every other year.

Other Income (Expense) – Other income (expense) consists of foreign currency exchange gain (loss), interest income (expense) and other income (expense). Foreign currency exchange gains (losses) were $(31,250) and $9,747 for the three months ended November 30, 2018 and 2017, respectively. The shifts in the foreign currency exchange are related to significant fluctuations of foreign currencies against the U.S. dollar during the current period of Fiscal 2019. Interest income (expense), net was $6,640 and $(65) for the three months ended November 30, 2018 and 2017, respectively. Other income (expense) was $14 for the first quarter of Fiscal 2019 as compared to $(605) for the same period in the prior year.

Foreign currency exchange gains (losses) were $(130,122) and $27,188 for the six months ended November 30, 2018 and 2017, respectively. The shifts in the foreign currency exchange are related to significant fluctuations of foreign currencies against the U.S. dollar during the current period of Fiscal 2019. Interest income (expense), net was $13,847 and $33 for the six months ended November 30, 2018 and 2017, respectively. Other income (expense) was $28 for the first half of Fiscal 2019 as compared to $(600) for the same period in the prior year.

Income Taxes – The Company’s effective tax rate on consolidated net loss was 2.8% for the six months ended November 30, 2018. The effective tax rate on consolidated net loss differs from the federal statutory tax rate primarily due to changes in the deferred tax valuation allowance and certain expenses not being deductible for income tax reporting purposes. Management believes the effective tax rate for Fiscal 2019 will be approximately 9.8% due to the items noted above.

Net Income (Loss) – Net loss was $255,270, or $(0.06) per fully diluted share, for the three months ended November 30, 2018 as compared to net income of $103,248, or $0.03 per fully diluted share, for the three months ended November 30, 2017. Net loss was $467,089, or $(0.12) per fully diluted share, for the six months ended November 30, 2018 as compared to net loss of $30,850, or $(0.01) per fully diluted share, for the six months ended November 30, 2017.

LIQUIDITY AND CAPITAL RESOURCES

The Company’s working capital decreased $295,845 to $7,952,128 as of November 30, 2018 as compared to $8,247,973 as of May 31, 2018.

Cash, cash equivalents and restricted cash decreased $755,064 to $1,356,469 as of November 30, 2018 from $2,111,533 as of May 31, 2018. Cash used in operating activities totaled $853,226 for the six months ended November 30, 2018 as compared to cash used in operating activities of $235,037 for the six months ended November 30, 2017. The net loss of $467,089, along with increases in inventories and accounts receivable, primarily impacted the total cash used in operating activities for the six months ended November 30, 2018. The changes in accounts receivable and inventories had the largest impact on the cash used in operating activities for the six-month period ended November 30, 2017.

At November 30, 2018, the Company had accounts receivable of $2,184,906 as compared to $2,047,032 at May 31, 2018. The increase in accounts receivable of $137,874 was due to timing of receipts. Inventories increased $366,166 to $6,077,054 as of November 30, 2018 as compared to $5,710,888 at May 31, 2018, which is due primarily to the targeted increases in inventory levels within our SBS and Xact product lines. At November 30, 2018, total current liabilities increased $36,336 to $1,806,740, as compared to $1,770,404 at May 31, 2018. The increase in current liabilities is primarily due to the timing of payments to our vendors, sales representatives and Company personnel.

We believe that our existing cash and cash equivalents combined with the cash we anticipate generating from operating activities will be sufficient to meet our cash requirements for the foreseeable future. We do not have any significant commitments nor are we aware of any significant events or conditions that are likely to have a material impact on our liquidity or capital resources.

 

Page 18


Table of Contents

Risk Factors

Please refer to the risk factors disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended May 31, 2018 for a listing of factors that could cause actual results or events to differ materially from those contained in any forward-looking statements made by or on behalf of the Company.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

There have been no material changes from the information previously reported under Item 7A of our Annual Report on Form 10-K for the fiscal year ended May 31, 2018.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As of November 30, 2018, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and the Company’s Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures, as such term is defined in Rule 13a-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”). Based on the evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this Report, the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed in the Company’s Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to the Company’s management, including the Company’s Chief Executive Officer and the Company’s Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives, and management necessarily is required to use its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Changes in Internal Control Over Financial Reporting

There has been no change in the Company’s internal control over financial reporting that occurred during the Company’s fiscal quarter ended November 30, 2018 that has materially affected, or is reasonably likely to materially affect, such internal control over financial reporting.

 

Page 19


Table of Contents

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

On January 8, 2019, Schmitt Industries, Inc. (the “Company”) was served with a complaint filed by North American Satellite Corp., Insite Platform Partners, and Rick Humphreys (collectively, the “Plaintiffs”) in the Circuit Court of the State of Oregon against the Company. The complaint makes various allegations specific to patent infringement, tortious interference, unfair competition, conspiracy, conspiracy to induce breach of contract, and conversion, with the total amount of $10,000,000 being sought by the Plaintiffs. The Company believes the complaint is without merit and intends to defend the claim vigorously.

Item 6. Exhibits

 

Exhibit    Description
    3.1    Second Restated Articles of Incorporation of Schmitt Industries, Inc. [Form 10-K for the fiscal year ended May 31, 1998, Exhibit 3(i)].
    3.2    Second Restated Bylaws of Schmitt Industries, Inc. [Form 10-K for the fiscal year ended May  31, 1998, Exhibit 3(ii)].
    4.1    See Exhibits 3.1 and 3.2 for provisions of the Articles of Incorporation and Bylaws defining the rights of security holders.
  31.1    Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  31.2    Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  32.1    Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS    XBRL Instance Document.
101.SCH    XBRL Taxonomy Extension Schema Document.
101.CAL    XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB    XBRL Taxonomy Extension Label Linkbase Document.
101.PRE    XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF    XBRL Taxonomy Extension Definition Linkbase Document.

 

Page 20


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

     

SCHMITT INDUSTRIES, INC.

(Registrant)

Date: January 11, 2019      

/s/ Ann M. Ferguson

      Ann M. Ferguson, Chief Financial Officer and Treasurer

 

Page 21